Louis Raso, MD
Interventional Pain Medicine · Jupiter, FLNPI 1538167408
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $974,360 of the $1,346,385 with a category attached, or 72.4%. Boston Scientific accounts for 82.4% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $319,828 and has fallen 74.7% since, to $81,009 in 2025. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 992 payments — averaging $1357.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1.1M
- Aurora Spine, Inc.$143K
- Vertiflex, Inc.$52K
- Surgentec$28K
- Flospine LLC$7K
- Omnia Medical, LLC$4K
- plus $3K from 26 others
Across 63 payments — averaging $4037.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$240K
- Vertiflex, Inc.$14K
Across 2 payments — averaging $10,500 each. An ownership or investment interest held by the physician or an immediate family member.
- Atlas Spine, Inc.$21K
What the payments were for
- Consulting fees$226,07817%
- Speaking & faculty fees$974,36072%
- Travel & lodging$126,1459%
- Food & beverage$17,5381%
- Education$2,2660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 800 | $1,109,595 |
| Aurora Spine, Inc. | 33 | $142,625 |
| Vertiflex, Inc. | 57 | $51,735 |
| Surgentec | 6 | $28,300 |
| Flospine LLC | 3 | $7,450 |
| Omnia Medical, LLC | 1 | $4,000 |
| Collegium Pharmaceutical, Inc. | 33 | $503 |
| Vertos Medical, Inc. | 10 | $381 |
| Southern Spine, LLC | 1 | $240 |
| Painteq LLC | 2 | $231 |
| Abbott | 4 | $209 |
| Stimwave Technologies Incorporated | 1 | $180 |
| Curonix LLC | 1 | $129 |
| Interventional Pain Technologies Inc. | 1 | $106 |
| Scilex Pharmaceuticals Inc. | 7 | $95 |
| Orexo US, Inc. | 4 | $86 |
| Forte Bio-pharma LLC | 2 | $60 |
| Biodelivery Sciences International, Inc. | 3 | $49 |
| Pfizer | 3 | $47 |
| Daiichi Sankyo Inc. | 2 | $40 |
| West Therapeutics Development, LLC | 2 | $38 |
| MDD US Operations, LLC | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $38 |
| Spinal Simplicity, LLC | 1 | $30 |
| Sentynl Therapeutics, Inc. | 2 | $29 |
| Stryker | 1 | $27 |
| AbbVie(2 entities) | 2 | $27 |
| Amgen | 2 | $25 |
| Relievant Medsystems, Inc. | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$266,152
- WaveWriter Alpha Prime 16$166,266
- GENERAL - THERAPIES$155,497
- ZIP$142,625
- WAVEWRITER ALPHA$110,542
- Superion Indirect Decompression System$91,168
- GENERAL PAIN MANAGEMENT$75,851
- SUPERION$59,737
- Superion ISS$51,094
- VERIFLEX$39,775
- ION Facet Screw$23,894
- Key Lift Intralaminar Expandable System$4,450
- TiLink$4,400
- KeyLift Interlaminar Expandable Cage System$3,000
- ION Facet Screw System$2,250
- INFINION$1,000
- EMBLEM$580
- PRECISION$550
- SQ RX PULSE GENERATOR$438
- Intracept$437
How this compares
$1,346,385 in reported general payments places this provider in the 95th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 58 | $90,039 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,607 | $59,279 |
| Xtampza ErOxycodone Myristate | 58 | $55,868 |
| Nucynta ErTapentadol Hcl | 13 | $32,219 |
| NucyntaTapentadol Hcl | 18 | $24,449 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 963 | $21,264 |
| Morphine Sulfate ErMorphine Sulfate | 516 | $17,979 |
| Oxycodone Hcl | 660 | $13,094 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 70 | $11,733 |
| Hydromorphone Hcl | 125 | $9,352 |
| Fentanyl | 54 | $6,689 |
| Lidocaine | 56 | $4,487 |
| Pregabalin | 158 | $3,808 |
| Tramadol Hcl | 489 | $3,805 |
| Gabapentin | 348 | $3,087 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Nucynta | $503 | $112,53689 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Jupiter
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
- Andrea TrescotEast Palatka$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.